Initiates Review of Leach Technologies to Supplement U.S. Copper Production Kinterra Capital Corp. (“Kinterra”) today announced it has expanded its U.S. copper platform by completing the acquisition of 100% of the issued and outstanding shares of ASX-listed New World Resources Ltd (ASX: NWC) (“New World”) and its flagship Antler Copper Project (“Antler”) in Arizona. https://mma.prnewswire.com/media/2805053/Kinterra_Capital_Corp_Kinterra_Expands_U_S__Copper_Platform_by_C.jpg […]

~ Platform utilizes Ontology-Powered Knowledge Graph, Ontosphere, to deliver compounding value and continuous transformation ~ Early client deployments of the platform are demonstrating up to 60% efficiency gains, 50% reduction in incident resolution time, and measurable margin improvements Mphasis, (BSE: 526299; NSE: MPHASIS), an Information Technology (IT) solutions provider specializing incloud andcognitive services, announced the

ATNM-400 exhibits superior efficacy with 3-5x greater tumor growth inhibition compared to front line therapy osimertinib (EGFR TKI TAGRISSO®), second line therapy Dato-DXd (Trop-2 ADC DATROWAY®) and third line therapy amivantamab (EGFR-cMET bispecific RYBREVANT®) Combination of ATNM-400 and osimertinib resulted in complete tumor regression in 100% of tumor bearing animals; synergistic mechanism supported by increased

Conference Call Scheduled for Monday, November 3, 2025, at 8:00 a.m. ET — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it will report third quarter 2025 financial results on Monday, November 3, 2025. Karyopharm's management team will host a conference call and audio webcast at 8:00 a.m.

Max Stock Limited (TASE: MAXO) (the “Company”) today announced it will host a conference call (LINK) on November 19, 2025 at 8:00 a.m. Eastern Time / 3:00 p.m. IL to discuss its third quarter 2025 financial results and nine months fiscal 2025 results. Nir Dagan, Deputy CEO and Head of Finance, and Talia Sessler, Chief

Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced lower-embodied-carbon steel product offerings, BIOEDGE™ and EDGE™, to support customers in achieving their greenhouse gas emissions reduction and sustainability initiatives. https://mma.prnewswire.com/media/1679329/Steel_Dynamics_Logo.jpg BIOEDGE and EDGE are lower-embodied-carbon steel products produced exclusively with electric arc furnace (EAF) technology. Additionally, the steel is matched with Green-e Energy certified renewable energy certificates

Great things are happening at a state-of-the-art recording studio tucked away in a hidden corner of Goodwin Hall on the south side of Auburn University's campus. https://mma.prnewswire.com/media/2803151/Student_playing_guitar.jpg Beautiful music is being made at the Don and Alexandra Clayton “Lucky Man” Studio, a world-class facility in the Department of Music that opened in October 2024. Whether

— Companies Unite to Deliver Nuclear Energy on Time and on Budget, Ensuring America's Premier Position in the Race to Power Tomorrow's Intelligence with the World's Leading Tech Companies — Hyundai E&C Inks Front-End Engineering Design (FEED) Contract to Provide America's First Clean New Nuclear Power at World's Largest Private Grid — Doosan Enerbility Inks

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, announced today that President and Chief Scientific Officer, Samarendra Mohanty, Ph.D., will be a featured speaker at the 2025 ISPE Annual Meeting and Expo, to be held October 26-29,

— Third Independent Data Monitoring Committee (IDMC) review confirms safety and continuation of the study — 94 patients enrolled out of 102 planned across Korea and the U.S. — Interim baseline characteristics to be presented at the 2025KATRD International Conference Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) announced that its first-in-class idiopathic pulmonary fibrosis